These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 24376174

  • 21. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
    Dosler S, Karaaslan E.
    Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
    [Abstract] [Full Text] [Related]

  • 22. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE, Orazi G, Ruoff KL, Hebert WP, O'Toole GA, Mastoridis P.
    PLoS One; 2015 Dec; 10(10):e0141192. PubMed ID: 26506004
    [Abstract] [Full Text] [Related]

  • 23. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
    Lu Q, Yu J, Bao L, Ran T, Zhong H.
    Chemotherapy; 2013 Dec; 59(1):51-6. PubMed ID: 23816803
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W, Noreddin A.
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [Abstract] [Full Text] [Related]

  • 25. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
    Coban AY, Ciftci A, Onuk EE, Erturan Z, Tanriverdi Cayci Y, Durupinar B.
    Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
    [Abstract] [Full Text] [Related]

  • 26. Zingerone inhibit biofilm formation and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas aeruginosa PAO1.
    Kumar L, Chhibber S, Harjai K.
    Fitoterapia; 2013 Oct; 90():73-8. PubMed ID: 23831483
    [Abstract] [Full Text] [Related]

  • 27. Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin.
    Ołdak E, Trafny EA.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3281-8. PubMed ID: 16048937
    [Abstract] [Full Text] [Related]

  • 28. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY, Ko KS, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [Abstract] [Full Text] [Related]

  • 29. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.
    Ciofu O, Mandsberg LF, Wang H, Høiby N.
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844
    [Abstract] [Full Text] [Related]

  • 30. Effects of ginseng on Pseudomonas aeruginosa motility and biofilm formation.
    Wu H, Lee B, Yang L, Wang H, Givskov M, Molin S, Høiby N, Song Z.
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):49-56. PubMed ID: 21303421
    [Abstract] [Full Text] [Related]

  • 31. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N, Ciofu O, Bjarnsholt T.
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [Abstract] [Full Text] [Related]

  • 32. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y, Yu XH, Wang R, An MM, Liang BB.
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [Abstract] [Full Text] [Related]

  • 33. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA.
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [Abstract] [Full Text] [Related]

  • 34. Stationary biofilm growth normalizes mutation frequencies and mutant prevention concentrations in Pseudomonas aeruginosa from cystic fibrosis patients.
    García-Castillo M, del Campo R, Baquero F, Morosini MI, Turrientes MC, Zamora J, Cantón R.
    Clin Microbiol Infect; 2011 May; 17(5):704-11. PubMed ID: 20673272
    [Abstract] [Full Text] [Related]

  • 35. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM, Monteiro R, Pereira MO.
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [Abstract] [Full Text] [Related]

  • 36. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR, White A, Elborn JS, Tunney MM.
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [Abstract] [Full Text] [Related]

  • 37. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.
    Aaron SD, Ferris W, Ramotar K, Vandemheen K, Chan F, Saginur R.
    J Clin Microbiol; 2002 Nov; 40(11):4172-9. PubMed ID: 12409393
    [Abstract] [Full Text] [Related]

  • 38. Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.
    Bjarnsholt T, Tolker-Nielsen T, Høiby N, Givskov M.
    Expert Rev Mol Med; 2010 Apr 07; 12():e11. PubMed ID: 20370936
    [Abstract] [Full Text] [Related]

  • 39. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
    Zhao T, Liu Y.
    BMC Microbiol; 2010 May 12; 10():140. PubMed ID: 20462423
    [Abstract] [Full Text] [Related]

  • 40. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
    Jakobsen TH, Bjarnsholt T, Jensen PØ, Givskov M, Høiby N.
    Future Microbiol; 2013 Jul 12; 8(7):901-21. PubMed ID: 23841636
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.